Viridian Therapeutics, Inc.\DE

StoneCrest Wealth Management, Inc. VRDN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/16/2026

Shares

24,920

Value ($000)

776

Weight

0.3%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/16/2026	776	0.3%	24,920	12/31/2025
2025 Q3	10/23/2025	539	0.2%	24,977	9/30/2025
2025 Q2	7/15/2025	350	0.2%	25,070	6/30/2025